Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Frits Van Rhee

Concepts (585)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
165
2025
3013
11.570
Why?
Antibodies, Monoclonal
26
2024
475
5.940
Why?
Hematopoietic Stem Cell Transplantation
28
2024
600
3.170
Why?
Antineoplastic Combined Chemotherapy Protocols
42
2024
1020
3.120
Why?
Antineoplastic Agents
18
2024
1216
3.100
Why?
Humans
220
2025
52441
2.200
Why?
Monoclonal Gammopathy of Undetermined Significance
11
2025
123
1.970
Why?
Thalidomide
24
2024
376
1.910
Why?
Neoplasm Recurrence, Local
15
2024
639
1.710
Why?
Immunotherapy, Adoptive
9
2024
156
1.670
Why?
Killer Cells, Natural
8
2024
111
1.640
Why?
Transplantation, Autologous
26
2024
479
1.640
Why?
Gene Expression Profiling
28
2025
1099
1.590
Why?
Middle Aged
81
2025
13133
1.580
Why?
Interleukin-6
12
2023
271
1.560
Why?
Neoplasm Proteins
13
2022
328
1.500
Why?
Hematologic Neoplasms
3
2022
101
1.500
Why?
Prognosis
48
2025
2100
1.460
Why?
Aged
81
2025
10242
1.420
Why?
Antigens, Neoplasm
6
2014
145
1.350
Why?
Clinical Trials as Topic
13
2022
461
1.350
Why?
Antibodies, Bispecific
7
2025
104
1.320
Why?
Stem Cell Transplantation
10
2022
188
1.270
Why?
B-Cell Maturation Antigen
9
2025
95
1.250
Why?
Adult
61
2025
14205
1.240
Why?
Gene Expression Regulation, Neoplastic
20
2022
853
1.190
Why?
Male
91
2025
26874
1.180
Why?
Combined Modality Therapy
19
2024
641
1.180
Why?
Female
93
2025
28277
1.170
Why?
Chromosomes, Human, Pair 1
9
2023
95
1.160
Why?
Herpesvirus 8, Human
7
2021
97
1.140
Why?
Translocation, Genetic
10
2022
266
1.110
Why?
Treatment Outcome
47
2024
5508
1.050
Why?
Boronic Acids
12
2013
180
1.040
Why?
Pyrazines
12
2013
187
1.040
Why?
Bone Marrow
18
2024
354
0.990
Why?
Plasma Cells
12
2025
233
0.980
Why?
Proteasome Inhibitors
5
2024
101
0.980
Why?
Immunotherapy
6
2024
251
0.930
Why?
Neoplasms, Second Primary
2
2024
75
0.920
Why?
Disease-Free Survival
24
2019
461
0.880
Why?
B-Lymphocytes
5
2024
178
0.850
Why?
Dexamethasone
14
2024
434
0.850
Why?
T-Lymphocytes, Cytotoxic
4
2014
64
0.830
Why?
Melphalan
9
2020
176
0.820
Why?
Cancer Vaccines
3
2010
78
0.810
Why?
Follow-Up Studies
26
2024
2294
0.800
Why?
Hyperhidrosis
1
2022
2
0.770
Why?
Sweat
1
2022
9
0.760
Why?
Survival Rate
24
2020
944
0.750
Why?
Lymphoma, B-Cell
3
2022
60
0.740
Why?
Drug Approval
1
2022
39
0.740
Why?
Positron-Emission Tomography
8
2025
297
0.720
Why?
Patient Participation
1
2022
65
0.710
Why?
Ehrlichia chaffeensis
1
2021
4
0.700
Why?
T-Lymphocytes
8
2024
318
0.700
Why?
Ehrlichiosis
1
2021
14
0.700
Why?
Cryosurgery
1
2021
36
0.690
Why?
Aged, 80 and over
23
2025
3449
0.690
Why?
Disease Progression
17
2025
870
0.680
Why?
Immunoglobulin Light Chains
3
2017
90
0.680
Why?
Lymphohistiocytosis, Hemophagocytic
1
2021
30
0.670
Why?
Embolization, Therapeutic
1
2021
93
0.650
Why?
Cell Proliferation
10
2023
1013
0.640
Why?
Neoplasm, Residual
9
2025
169
0.630
Why?
Chromosomal Instability
1
2019
16
0.620
Why?
Neoplasms, Plasma Cell
3
2024
35
0.610
Why?
Membrane Proteins
3
2006
344
0.600
Why?
Survival Analysis
18
2024
656
0.600
Why?
Adrenal Cortex Hormones
2
2023
116
0.590
Why?
Immunologic Factors
2
2018
114
0.590
Why?
Epigenesis, Genetic
4
2023
396
0.570
Why?
Chromosome Aberrations
12
2023
295
0.570
Why?
Tumor Microenvironment
6
2024
257
0.560
Why?
Dendritic Cells
3
2014
132
0.560
Why?
POEMS Syndrome
1
2018
34
0.560
Why?
Atrial Fibrillation
2
2022
196
0.550
Why?
Thyroid Neoplasms
1
2019
111
0.550
Why?
Polymorphism, Single Nucleotide
3
2024
506
0.530
Why?
Prealbumin
2
2014
22
0.530
Why?
Antibodies, Monoclonal, Humanized
6
2023
230
0.520
Why?
Receptors, Interleukin-6
2
2014
22
0.510
Why?
Cardiomyopathies
2
2014
117
0.480
Why?
Mutation
10
2022
1331
0.470
Why?
Risk Assessment
11
2025
1349
0.460
Why?
Osteolysis
4
2022
74
0.450
Why?
Immunotoxins
1
2014
6
0.440
Why?
Cytotoxicity, Immunologic
2
2012
55
0.430
Why?
Recurrence
13
2024
680
0.430
Why?
Risk Factors
20
2025
3971
0.420
Why?
Drug Resistance, Neoplasm
7
2024
336
0.420
Why?
Clonal Evolution
3
2020
57
0.420
Why?
Practice Guidelines as Topic
4
2023
498
0.410
Why?
Health Status
1
2015
300
0.400
Why?
Cyclophosphamide
5
2021
176
0.400
Why?
Amyloidosis
1
2014
85
0.400
Why?
Transplantation, Homologous
5
2017
151
0.400
Why?
Thrombocytopenia
3
2025
93
0.390
Why?
Diffusion Magnetic Resonance Imaging
3
2025
131
0.390
Why?
Fluorodeoxyglucose F18
6
2021
181
0.390
Why?
Remission Induction
13
2021
218
0.370
Why?
Neutropenia
2
2023
113
0.370
Why?
Genome-Wide Association Study
3
2024
184
0.370
Why?
Receptors, KIR
2
2008
11
0.360
Why?
Bone Diseases
3
2021
91
0.350
Why?
Genetic Predisposition to Disease
3
2024
525
0.350
Why?
Dose-Response Relationship, Drug
8
2020
1365
0.350
Why?
Prospective Studies
9
2025
2433
0.350
Why?
Pyrimidines
2
2022
199
0.350
Why?
Cytokines
3
2025
622
0.350
Why?
Lymph Nodes
5
2025
253
0.350
Why?
Azacitidine
1
2010
39
0.340
Why?
Benzamides
1
2010
52
0.340
Why?
Evolution, Molecular
2
2021
98
0.330
Why?
Histone Deacetylase Inhibitors
1
2010
57
0.330
Why?
C-Reactive Protein
6
2022
151
0.320
Why?
Prednisone
2
2021
100
0.320
Why?
Doxorubicin
6
2021
246
0.320
Why?
Drug Administration Schedule
5
2015
370
0.310
Why?
TOR Serine-Threonine Kinases
2
2020
83
0.310
Why?
Chromosome Deletion
5
2023
138
0.310
Why?
Pelvis
2
2021
65
0.300
Why?
Metaphase
4
2016
47
0.300
Why?
Vaccination
4
2022
294
0.300
Why?
Quality of Life
1
2015
893
0.300
Why?
Membrane Glycoproteins
2
2009
239
0.300
Why?
Paraproteinemias
3
2022
72
0.290
Why?
Animals
15
2024
13485
0.290
Why?
Disease Management
3
2025
185
0.290
Why?
Proportional Hazards Models
7
2024
446
0.290
Why?
Placebo Effect
2
2020
16
0.280
Why?
Young Adult
8
2025
4346
0.280
Why?
Fever
3
2025
112
0.280
Why?
Bone Neoplasms
4
2013
188
0.280
Why?
Adoptive Transfer
1
2007
30
0.280
Why?
Histocompatibility Antigens Class I
1
2007
47
0.270
Why?
Chromatin
3
2023
143
0.270
Why?
CD8-Positive T-Lymphocytes
3
2024
140
0.270
Why?
Cytogenetic Analysis
5
2023
79
0.270
Why?
DNA Methylation
4
2023
573
0.260
Why?
Boron Compounds
2
2024
19
0.260
Why?
Registries
4
2025
638
0.260
Why?
Chromans
2
2024
34
0.260
Why?
Vincristine
3
2021
89
0.260
Why?
Cell Membrane
1
2007
238
0.250
Why?
Mice, SCID
6
2013
178
0.250
Why?
Angiogenesis Inhibitors
5
2010
183
0.250
Why?
Glycine
2
2024
78
0.250
Why?
Down-Regulation
1
2007
348
0.250
Why?
In Situ Hybridization, Fluorescence
5
2023
262
0.250
Why?
Neoplasm Staging
6
2024
768
0.240
Why?
Cell Line, Tumor
9
2023
1429
0.240
Why?
Consensus
3
2025
195
0.240
Why?
Chromosomes, Human, Pair 17
2
2017
35
0.240
Why?
Vitamin E
2
2024
77
0.240
Why?
Mice
11
2024
5899
0.240
Why?
Transplantation Conditioning
5
2008
93
0.230
Why?
Case-Control Studies
6
2024
1202
0.230
Why?
Bone Resorption
2
2022
300
0.230
Why?
Infusions, Intravenous
3
2015
212
0.230
Why?
Flow Cytometry
4
2012
396
0.230
Why?
Connective Tissue Diseases
1
2025
18
0.230
Why?
Antibody Formation
1
2005
51
0.230
Why?
Retrospective Studies
12
2025
6694
0.220
Why?
Immunoglobulins, Intravenous
1
2025
63
0.220
Why?
Time Factors
11
2021
2987
0.220
Why?
Polycomb Repressive Complex 2
2
2021
47
0.220
Why?
Autoantibodies
1
2025
118
0.220
Why?
Monocytes
2
2020
124
0.210
Why?
Gene Expression
2
2018
618
0.210
Why?
High-Throughput Nucleotide Sequencing
3
2022
178
0.210
Why?
Cell Cycle Proteins
2
2022
168
0.210
Why?
Blotting, Western
3
2015
587
0.200
Why?
Signal Transduction
6
2021
1724
0.200
Why?
Epstein-Barr Virus Infections
2
2020
31
0.200
Why?
Proteasome Endopeptidase Complex
3
2011
137
0.200
Why?
Radiation-Protective Agents
1
2024
69
0.200
Why?
Ubiquitin-Protein Ligases
1
2024
132
0.200
Why?
Integrin beta Chains
1
2023
14
0.200
Why?
Integrins
1
2023
31
0.200
Why?
Cross-Sectional Studies
3
2023
1677
0.200
Why?
Double-Blind Method
2
2015
726
0.190
Why?
Sweating
1
2022
13
0.190
Why?
Hematopoietic Stem Cells
2
2022
180
0.190
Why?
Proto-Oncogene Proteins B-raf
2
2020
75
0.190
Why?
Tumor Cells, Cultured
4
2013
441
0.190
Why?
Kaplan-Meier Estimate
10
2016
485
0.190
Why?
Proteomics
3
2021
332
0.190
Why?
DNA, Intergenic
1
2022
6
0.190
Why?
Immunoconjugates
1
2022
37
0.180
Why?
Receptors, Antigen, T-Cell
1
2022
48
0.180
Why?
Tumor Suppressor Protein p53
2
2017
224
0.180
Why?
Waldenstrom Macroglobulinemia
1
2022
38
0.180
Why?
United States
4
2022
5215
0.180
Why?
United States Food and Drug Administration
1
2022
89
0.180
Why?
Influenza, Human
1
2022
90
0.180
Why?
Mediastinum
1
2021
21
0.180
Why?
Chromosomes, Human, Pair 14
3
2020
76
0.180
Why?
Apoptosis
5
2018
1120
0.180
Why?
Receptors, Glucocorticoid
2
2012
35
0.180
Why?
Epigenomics
1
2021
75
0.180
Why?
Phosphatidylinositol 3-Kinases
2
2019
147
0.170
Why?
Axilla
1
2021
92
0.170
Why?
Ubiquitination
1
2021
57
0.170
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
90
0.170
Why?
Multiple Organ Failure
1
2021
48
0.170
Why?
Alleles
3
2021
279
0.170
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
108
0.170
Why?
Salvage Therapy
6
2013
137
0.170
Why?
Proto-Oncogene Proteins c-maf
2
2020
19
0.170
Why?
Adolescent
7
2025
6713
0.170
Why?
Epstein-Barr Virus Nuclear Antigens
1
2020
1
0.170
Why?
Interferon-gamma
3
2014
169
0.170
Why?
Rare Diseases
1
2020
47
0.170
Why?
Transcriptome
5
2025
357
0.170
Why?
Genes, Tumor Suppressor
2
2021
73
0.170
Why?
Radiopharmaceuticals
4
2021
198
0.170
Why?
Cell Cycle
1
2021
236
0.160
Why?
Longitudinal Studies
5
2024
756
0.160
Why?
Interferon Type I
1
2020
28
0.160
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.160
Why?
Myelodysplastic Syndromes
2
2013
86
0.160
Why?
Leukemia, Plasma Cell
1
2020
33
0.160
Why?
ROC Curve
2
2025
249
0.160
Why?
Multivariate Analysis
8
2021
601
0.160
Why?
Genomics
4
2023
266
0.160
Why?
Research Design
2
2020
368
0.160
Why?
DNA
1
2023
544
0.160
Why?
Gene Amplification
1
2019
59
0.160
Why?
Measles virus
1
2019
8
0.160
Why?
Immunohistochemistry
2
2015
977
0.160
Why?
Measles
1
2019
7
0.160
Why?
Data Collection
1
2020
285
0.160
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.150
Why?
Gene Regulatory Networks
1
2020
112
0.150
Why?
Oncolytic Virotherapy
1
2019
19
0.150
Why?
Health Status Disparities
1
2022
218
0.150
Why?
Biopsy
5
2018
594
0.150
Why?
Patient Safety
1
2020
102
0.150
Why?
Sirolimus
1
2019
72
0.150
Why?
Healthcare Disparities
1
2022
291
0.150
Why?
Cell Differentiation
6
2022
667
0.150
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
9
0.150
Why?
Evidence-Based Medicine
2
2018
271
0.150
Why?
Precancerous Conditions
2
2010
87
0.150
Why?
Syndrome
1
2019
247
0.150
Why?
Proto-Oncogene Proteins c-akt
1
2019
168
0.150
Why?
MafB Transcription Factor
1
2018
9
0.140
Why?
Spleen
1
2019
166
0.140
Why?
Graft vs Host Disease
4
2007
91
0.140
Why?
Genomic Instability
2
2016
87
0.140
Why?
Immunomodulation
1
2018
36
0.140
Why?
Phosphotransferases
1
2018
17
0.140
Why?
Chemokines
1
2018
77
0.140
Why?
Plasma
1
2018
47
0.140
Why?
Osteoclasts
3
2022
423
0.140
Why?
Myeloablative Agonists
2
2008
32
0.140
Why?
Hematopoietic Stem Cell Mobilization
2
2008
60
0.140
Why?
Magnetic Resonance Imaging
5
2013
1507
0.140
Why?
Adipocytes
1
2018
127
0.140
Why?
Models, Biological
2
2018
735
0.140
Why?
Genes, Neoplasm
2
2015
31
0.140
Why?
Gene Dosage
2
2015
73
0.140
Why?
Gene Rearrangement
1
2018
76
0.130
Why?
Communication
1
2019
255
0.130
Why?
Hexokinase
1
2017
16
0.130
Why?
Heterozygote
2
2014
89
0.130
Why?
Protein-Tyrosine Kinases
2
2018
92
0.130
Why?
Calcification, Physiologic
1
2017
42
0.130
Why?
HLA-A Antigens
2
2007
11
0.130
Why?
Drug Therapy, Combination
1
2018
404
0.130
Why?
Oligonucleotide Array Sequence Analysis
5
2010
412
0.130
Why?
Gene Frequency
2
2013
97
0.120
Why?
Syndecan-1
4
2021
73
0.120
Why?
Gene Expression Regulation, Enzymologic
1
2017
180
0.120
Why?
Critical Illness
1
2018
306
0.120
Why?
Lymphocyte Activation
2
2017
161
0.120
Why?
Tumor Burden
3
2020
132
0.120
Why?
Immunity, Innate
1
2016
109
0.120
Why?
Confidence Intervals
2
2014
158
0.120
Why?
Erythrocyte Indices
1
2015
6
0.120
Why?
Biomarkers, Pharmacological
2
2012
26
0.120
Why?
DNA Copy Number Variations
3
2022
116
0.120
Why?
Coculture Techniques
2
2013
142
0.110
Why?
Hemoglobins
2
2013
114
0.110
Why?
Cysteine-Rich Protein 61
1
2014
3
0.110
Why?
Hematologic Diseases
1
2014
21
0.110
Why?
Half-Life
1
2014
86
0.110
Why?
International Cooperation
1
2014
52
0.110
Why?
Iron
1
2015
123
0.110
Why?
Fatigue
1
2015
126
0.110
Why?
Enzyme-Linked Immunosorbent Assay
1
2015
234
0.110
Why?
Area Under Curve
1
2014
182
0.110
Why?
Antibodies
2
2024
144
0.110
Why?
Amyloid Neuropathies, Familial
1
2013
5
0.110
Why?
Reference Values
1
2014
316
0.100
Why?
Renal Insufficiency
2
2021
109
0.100
Why?
Emotions
1
2015
172
0.100
Why?
Disease Models, Animal
2
2016
1483
0.100
Why?
Antineoplastic Agents, Alkylating
3
2008
78
0.100
Why?
Neoplasms, Glandular and Epithelial
1
2014
41
0.100
Why?
Severity of Illness Index
2
2014
1045
0.100
Why?
Administration, Metronomic
1
2013
7
0.100
Why?
Inflammation Mediators
1
2014
113
0.100
Why?
Cystatin M
2
2024
17
0.100
Why?
Cisplatin
4
2013
282
0.100
Why?
Macaca mulatta
2
2024
94
0.100
Why?
Nicotinamide Phosphoribosyltransferase
1
2013
6
0.100
Why?
Central Nervous System Neoplasms
1
2013
69
0.100
Why?
beta Catenin
1
2013
105
0.100
Why?
Oligopeptides
1
2013
94
0.100
Why?
Venous Thrombosis
2
2004
89
0.100
Why?
Antibody-Dependent Cell Cytotoxicity
2
2009
11
0.100
Why?
Edema
2
2025
63
0.100
Why?
Leukemia
1
2013
67
0.100
Why?
Myelolipoma
1
2012
9
0.100
Why?
Cell Survival
2
2020
598
0.100
Why?
Mental Health
1
2015
237
0.100
Why?
Pain
1
2015
373
0.090
Why?
Interleukin Receptor Common gamma Subunit
1
2012
7
0.090
Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
8
0.090
Why?
Clone Cells
2
2023
76
0.090
Why?
Maintenance Chemotherapy
1
2012
52
0.090
Why?
Vascular Endothelial Growth Factor A
1
2013
186
0.090
Why?
Adaptor Proteins, Signal Transducing
2
2024
202
0.090
Why?
Models, Genetic
2
2016
173
0.090
Why?
Interleukin-2
1
2012
69
0.090
Why?
Mice, Inbred NOD
1
2012
91
0.090
Why?
Immunoenzyme Techniques
1
2012
134
0.090
Why?
Cell Movement
1
2013
271
0.090
Why?
Hemangioma
1
2013
86
0.090
Why?
Soft Tissue Neoplasms
1
2012
56
0.090
Why?
Arkansas
5
2021
2013
0.090
Why?
Immunoglobulin G
2
2025
193
0.090
Why?
Genotype
1
2013
563
0.090
Why?
Transcriptional Elongation Factors
2
2022
17
0.090
Why?
Transduction, Genetic
2
2014
44
0.090
Why?
Models, Statistical
2
2014
230
0.090
Why?
Chemokine CXCL13
2
2022
6
0.090
Why?
Peripheral Blood Stem Cell Transplantation
2
2008
58
0.080
Why?
Mutation Rate
2
2021
36
0.080
Why?
Immunoglobulin Idiotypes
1
2010
5
0.080
Why?
CD40 Ligand
1
2010
14
0.080
Why?
Hypersensitivity, Delayed
1
2010
18
0.080
Why?
Interleukin-4
1
2010
41
0.080
Why?
Secondary Prevention
1
2010
85
0.080
Why?
Up-Regulation
4
2018
462
0.080
Why?
HIV Seropositivity
1
2010
28
0.080
Why?
Eukaryotic Initiation Factor-2
1
2010
17
0.080
Why?
Immunity, Cellular
1
2010
64
0.080
Why?
Adjuvants, Immunologic
1
2010
51
0.080
Why?
Cell Line
2
2013
1020
0.080
Why?
Cells, Cultured
3
2013
1583
0.080
Why?
Ovarian Neoplasms
1
2014
455
0.080
Why?
Etoposide
2
2007
70
0.080
Why?
Placenta
1
2011
147
0.080
Why?
Transplantation, Heterologous
1
2009
78
0.080
Why?
Radiography
4
2012
469
0.080
Why?
Histones
2
2021
315
0.070
Why?
Polymerase Chain Reaction
1
2010
458
0.070
Why?
Hospitalization
2
2024
731
0.070
Why?
Cytotoxicity Tests, Immunologic
1
2008
26
0.070
Why?
Transcription Factors
2
2023
570
0.070
Why?
Liver Neoplasms
1
2012
341
0.070
Why?
Bone and Bones
3
2021
492
0.070
Why?
Lymphocyte Subsets
1
2008
14
0.070
Why?
Neoplastic Stem Cells
1
2009
88
0.070
Why?
Immunoglobulin lambda-Chains
1
2008
15
0.070
Why?
Granulocyte Colony-Stimulating Factor
1
2008
64
0.070
Why?
Haplotypes
1
2008
95
0.070
Why?
Cytogenetics
1
2008
23
0.070
Why?
Gene Deletion
1
2009
279
0.070
Why?
Osteogenesis
1
2011
368
0.070
Why?
Receptors, Immunologic
1
2008
35
0.070
Why?
Ligands
1
2008
205
0.070
Why?
Twins
1
2007
32
0.070
Why?
Busulfan
1
2007
18
0.070
Why?
Diphosphonates
1
2008
92
0.070
Why?
Herpesviridae Infections
2
2019
57
0.070
Why?
Immunophenotyping
1
2007
115
0.070
Why?
Leukocytes, Mononuclear
1
2007
122
0.070
Why?
Caspases
2
2018
101
0.070
Why?
Antimetabolites
1
2006
12
0.070
Why?
Skin Neoplasms
1
2012
496
0.060
Why?
Creatinine
1
2007
156
0.060
Why?
Blood Proteins
1
2007
84
0.060
Why?
Antibodies, Neoplasm
1
2006
27
0.060
Why?
Immunosuppressive Agents
1
2008
248
0.060
Why?
Graft vs Leukemia Effect
1
2006
2
0.060
Why?
Chromosome Banding
1
2006
24
0.060
Why?
Plasmacytoma
1
2006
44
0.060
Why?
Cohort Studies
3
2020
1576
0.060
Why?
MicroRNAs
1
2010
392
0.060
Why?
Bone Marrow Transplantation
2
2022
110
0.060
Why?
Amiloride
1
2005
8
0.060
Why?
HLA-A2 Antigen
1
2005
11
0.060
Why?
Imaging, Three-Dimensional
2
2017
150
0.060
Why?
Decision Trees
1
2025
23
0.060
Why?
Sensitivity and Specificity
1
2007
871
0.060
Why?
Tomography, X-Ray Computed
2
2023
1140
0.060
Why?
Child
3
2025
7194
0.060
Why?
Predictive Value of Tests
3
2018
938
0.060
Why?
Poly(ADP-ribose) Polymerases
2
2016
30
0.060
Why?
Japan
1
2025
40
0.060
Why?
Autoantigens
1
2025
47
0.060
Why?
Transmembrane Activator and CAML Interactor Protein
1
2024
6
0.060
Why?
Mendelian Randomization Analysis
1
2024
7
0.060
Why?
Phthalimides
1
2024
2
0.060
Why?
Piperidones
1
2024
6
0.050
Why?
Enoxaparin
1
2004
31
0.050
Why?
Telomere
1
2024
39
0.050
Why?
Retreatment
1
2024
58
0.050
Why?
Morpholines
1
2024
64
0.050
Why?
NF-kappa B
2
2018
326
0.050
Why?
Ferritins
1
2024
36
0.050
Why?
Myeloid Progenitor Cells
1
2023
15
0.050
Why?
Cost of Illness
1
2024
120
0.050
Why?
X-Ray Microtomography
1
2024
79
0.050
Why?
Neoplasms
1
2014
1314
0.050
Why?
Receptors, G-Protein-Coupled
1
2024
57
0.050
Why?
Epidemiologic Methods
3
2008
47
0.050
Why?
DNA, Neoplasm
2
2020
146
0.050
Why?
Gene Silencing
2
2016
122
0.050
Why?
Fibroblasts
1
2005
357
0.050
Why?
Cluster Analysis
3
2010
236
0.050
Why?
Cell Communication
1
2023
74
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Patients
1
2022
50
0.050
Why?
Geography
1
2022
65
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
32
0.050
Why?
Whole-Body Irradiation
1
2022
128
0.050
Why?
Phenotype
1
2025
792
0.050
Why?
Guanine Nucleotide Exchange Factors
1
2022
18
0.050
Why?
Inheritance Patterns
1
2022
22
0.050
Why?
Primary Cell Culture
1
2022
63
0.050
Why?
Risk
2
2014
315
0.050
Why?
Quantitative Trait Loci
1
2022
52
0.050
Why?
Chromosomal Proteins, Non-Histone
1
2022
36
0.050
Why?
Patient Selection
1
2023
269
0.050
Why?
Oncogenes
1
2021
61
0.040
Why?
Phylogeny
1
2022
229
0.040
Why?
Anticoagulants
1
2004
276
0.040
Why?
Age of Onset
2
2013
109
0.040
Why?
Child, Preschool
2
2020
4046
0.040
Why?
RANK Ligand
1
2022
188
0.040
Why?
Rabbits
2
2013
370
0.040
Why?
SOXC Transcription Factors
1
2021
13
0.040
Why?
Polymorphism, Genetic
1
2022
184
0.040
Why?
Transcriptional Activation
1
2021
127
0.040
Why?
Base Sequence
1
2022
632
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
67
0.040
Why?
Repressor Proteins
1
2022
150
0.040
Why?
Cyclin D2
1
2020
21
0.040
Why?
Fibrosis
1
2021
198
0.040
Why?
Spatio-Temporal Analysis
1
2020
11
0.040
Why?
Aneuploidy
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
ras Proteins
1
2020
62
0.040
Why?
Histone Code
1
2020
32
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
31
0.040
Why?
Cyclin D1
1
2020
59
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
56
0.040
Why?
Genome, Human
1
2021
121
0.040
Why?
Protein Kinase Inhibitors
1
2022
231
0.040
Why?
Single-Cell Analysis
1
2020
71
0.040
Why?
Genetic Loci
1
2020
46
0.040
Why?
Mice, Transgenic
1
2021
566
0.040
Why?
False Negative Reactions
1
2019
31
0.040
Why?
DNA Mutational Analysis
1
2020
179
0.040
Why?
Neoplasm Invasiveness
1
2020
278
0.040
Why?
Genetic Variation
1
2020
226
0.040
Why?
Incidence
2
2013
1096
0.040
Why?
Europe
1
2019
90
0.040
Why?
Herpesvirus 4, Human
1
2019
43
0.040
Why?
Communicable Disease Control
1
2019
37
0.040
Why?
Computational Biology
1
2020
209
0.040
Why?
Genome, Viral
1
2019
79
0.040
Why?
beta 2-Microglobulin
2
2009
39
0.040
Why?
DNA, Viral
1
2019
134
0.040
Why?
RNA, Messenger
2
2016
1134
0.040
Why?
Virus Diseases
1
2019
47
0.040
Why?
Fibrinogen
1
2018
31
0.040
Why?
Immunoglobulin A
1
2018
46
0.040
Why?
Glycogen Synthase Kinase 3
1
2018
21
0.040
Why?
DNA-Binding Proteins
1
2021
423
0.040
Why?
Bone Marrow Cells
2
2014
188
0.040
Why?
Platelet Count
2
2008
78
0.040
Why?
Promoter Regions, Genetic
1
2020
465
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
51
0.030
Why?
Pathology, Molecular
1
2018
27
0.030
Why?
Oncogene Proteins, Fusion
1
2018
61
0.030
Why?
Data Interpretation, Statistical
2
2010
166
0.030
Why?
Databases, Factual
2
2013
721
0.030
Why?
Kidney Function Tests
1
2017
56
0.030
Why?
False Positive Reactions
1
2017
64
0.030
Why?
Glomerular Filtration Rate
1
2017
126
0.030
Why?
Lamins
1
2016
5
0.030
Why?
Cell Transformation, Neoplastic
1
2018
187
0.030
Why?
Chromosomes, Human, Pair 16
1
2016
18
0.030
Why?
Amino Acid Sequence
1
2018
576
0.030
Why?
Internationality
1
2017
46
0.030
Why?
Alkaline Phosphatase
1
2017
92
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Genes, p53
1
2016
50
0.030
Why?
Lymphocytes, Tumor-Infiltrating
1
2017
86
0.030
Why?
Proteolysis
1
2016
100
0.030
Why?
Glycolysis
1
2016
70
0.030
Why?
Enzyme Activation
1
2016
269
0.030
Why?
Chromosome Mapping
2
2006
149
0.030
Why?
Prevalence
1
2019
1016
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
96
0.030
Why?
Phosphorylation
1
2016
536
0.030
Why?
Kidney Diseases
1
2017
230
0.030
Why?
Asymptomatic Diseases
1
2014
38
0.030
Why?
Gene Fusion
1
2014
9
0.030
Why?
Interspersed Repetitive Sequences
1
2014
7
0.030
Why?
Myocardium
1
2017
471
0.030
Why?
Karyotype
1
2014
18
0.030
Why?
Capsid
1
2014
3
0.030
Why?
Lymphocyte Culture Test, Mixed
1
2014
6
0.030
Why?
HIV-1
1
2014
60
0.030
Why?
Homozygote
1
2013
58
0.030
Why?
Cerebrospinal Fluid
1
2013
30
0.030
Why?
Diagnosis, Differential
1
2017
1028
0.030
Why?
Genetic Vectors
1
2014
128
0.030
Why?
Nicotinamide Mononucleotide
1
2013
4
0.030
Why?
Receptors, CXCR4
1
2013
31
0.020
Why?
Acrylamides
1
2013
9
0.020
Why?
Dependovirus
1
2014
104
0.020
Why?
Niacinamide
1
2013
24
0.020
Why?
Enzyme Induction
1
2013
78
0.020
Why?
Amides
1
2013
36
0.020
Why?
NAD
1
2013
46
0.020
Why?
Sirtuin 1
1
2013
29
0.020
Why?
Nitriles
1
2013
51
0.020
Why?
Chemokine CXCL12
1
2013
35
0.020
Why?
Gene Knockdown Techniques
1
2013
110
0.020
Why?
Transplantation Chimera
2
2003
16
0.020
Why?
RNA, Small Interfering
1
2013
217
0.020
Why?
Piperidines
1
2013
99
0.020
Why?
Infant
1
2020
3709
0.020
Why?
Lymphocyte Count
1
2011
20
0.020
Why?
Induction Chemotherapy
1
2012
65
0.020
Why?
Acute Disease
1
2013
384
0.020
Why?
Chemokine CXCL10
1
2011
20
0.020
Why?
HIV Infections
1
2016
394
0.020
Why?
Antibodies, Neutralizing
1
2011
79
0.020
Why?
Sex Factors
1
2013
735
0.020
Why?
Pharmacogenetics
1
2011
51
0.020
Why?
Enzyme Inhibitors
1
2013
378
0.020
Why?
Clinical Trials, Phase I as Topic
1
2010
24
0.020
Why?
Clinical Trials, Phase II as Topic
1
2010
48
0.020
Why?
Clinical Trials, Phase III as Topic
1
2010
49
0.020
Why?
Microarray Analysis
1
2010
69
0.020
Why?
International Classification of Diseases
1
2010
70
0.020
Why?
Argonaute Proteins
1
2010
12
0.020
Why?
RNA-Binding Proteins
1
2011
133
0.020
Why?
Oligonucleotides
1
2010
76
0.020
Why?
Polyploidy
1
2009
9
0.020
Why?
Bone Marrow Examination
1
2009
11
0.020
Why?
L-Lactate Dehydrogenase
1
2009
64
0.020
Why?
Neoplasm Metastasis
1
2009
235
0.020
Why?
Ploidies
1
2008
10
0.020
Why?
Chromosomes, Human, Pair 13
1
2008
38
0.020
Why?
Serum Albumin
1
2008
57
0.020
Why?
Polyethylene Glycols
1
2008
93
0.020
Why?
Xenograft Model Antitumor Assays
1
2008
218
0.020
Why?
Randomized Controlled Trials as Topic
1
2010
625
0.020
Why?
Age Distribution
1
2007
176
0.020
Why?
Recombinant Proteins
1
2008
490
0.020
Why?
Antineoplastic Agents, Hormonal
1
2007
56
0.020
Why?
Multigene Family
1
2006
49
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Syndecans
1
2006
37
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
RNA, Neoplasm
1
2006
45
0.020
Why?
Proteoglycans
1
2006
86
0.020
Why?
Leukemia, Myeloid, Acute
1
2007
202
0.010
Why?
Brain
1
2013
1337
0.010
Why?
Survivors
1
2006
121
0.010
Why?
Pregnancy
1
2011
2642
0.010
Why?
Lymphocyte Transfusion
1
2003
10
0.010
Why?
Probability
1
2003
171
0.010
Why?
Administration, Oral
1
2003
455
0.010
Why?
Tissue Donors
1
2003
126
0.010
Why?
Van Rhee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Same Department Expand Description